Genetic Technologies Limited (ASX:GTG)
Australia · Delayed Price · Currency is AUD 0.0390
0.00 (0.00%)
Oct 16, 2024, 1:07 PM AEST
Genetic Technologies Market Cap
Genetic Technologies has a market cap or net worth of 5.67 million as of October 7, 2026. That makes Genetic Technologies the world's 45,936th most valuable company and 1,515th in Australia. Its market cap has decreased by 75.43% in one year.
Market Cap
5.67M
Enterprise Value
5.51M
Revenue
n/a
Global Rank
Country Rank
#1,515 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 5, 1994, Genetic Technologies's market cap has increased from 3.80M to 5.67M, an increase of 49.21%. That is a compound annual growth rate of 1.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2024 | 5.67M | -63.60% |
| Dec 29, 2023 | 15.58M | -43.75% |
| Dec 30, 2022 | 27.70M | -40.00% |
| Dec 31, 2021 | 46.17M | -25.49% |
| Dec 31, 2020 | 61.96M | 177.27% |
| Dec 31, 2019 | 22.35M | 40.86% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2014 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 519.98M |
| Healius | 294.09M |
| Monash IVF Group | 290.28M |
| Cryosite | 56.13M |
| Microba Life Sciences | 33.61M |
| BCAL Diagnostics | 33.55M |
| Rhythm Biosciences | 27.60M |
| INOVIQ | 23.93M |